Background The use of anticoagulants is an established strategy to prevent stroke,
embolism, and cardiovascular mortality in patients with atrial fibrillation (AF), but its role in …

Background Treatment with vitamin K antagonists (VKAs) has been linked to worsening of
kidney function in patients with atrial fibrillation (AF). Objectives XARENO (Factor XA …

Background Oral anticoagulation therapy with warfarin or direct oral anticoagulants
(DOACs) is the mainstay for stroke prevention in patients with non‐valvular atrial fibrillation …

Background Patients with atrial fibrillation (AF) are routinely prescribed oral anticoagulants
to prevent thromboembolism. Concerns regarding the efficacy and safety of oral …

Background Life-long oral anticoagulation therapy with warfarin or direct oral anticoagulants
(DOACs) is the mainstay for stroke prevention in patients with non-valvular atrial fibrillation …